HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stig S Frøland Selected Research

Left Ventricular Dysfunction

6/2005Soluble CD40 ligand in acute and chronic heart failure.
5/2005Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stig S Frøland Research Topics

Disease

25Inflammation (Inflammations)
06/2012 - 02/2002
13Atherosclerosis
10/2009 - 07/2002
12Coronary Artery Disease (Coronary Atherosclerosis)
10/2009 - 07/2002
11Heart Failure
05/2009 - 04/2002
8Myocardial Infarction
05/2009 - 03/2004
8HIV Infections (HIV Infection)
01/2009 - 04/2003
7Acute Coronary Syndrome
10/2006 - 07/2002
6Common Variable Immunodeficiency
06/2010 - 06/2003
5Infections
09/2012 - 04/2005
5Unstable Angina
10/2006 - 07/2002
4Necrosis
09/2012 - 01/2004
4Atherosclerotic Plaque (Atheroma)
01/2009 - 07/2002
3Thrombosis (Thrombus)
06/2012 - 08/2004
3Disease Progression
01/2009 - 04/2003
3Stable Angina
04/2006 - 07/2002
2Pneumonia (Pneumonitis)
02/2018 - 01/2016
2Cardiovascular Diseases (Cardiovascular Disease)
01/2016 - 05/2006
2Bronchiectasis
09/2013 - 06/2010
2Bacterial Infections (Bacterial Infection)
06/2009 - 02/2009
2Spotted Fever Group Rickettsiosis (Rickettsialpox)
01/2009 - 08/2006
2Rupture
02/2007 - 04/2006
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
09/2006 - 11/2005
2Cardiomyopathies (Cardiomyopathy)
09/2006 - 10/2003
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2006 - 01/2003
2Hypertension (High Blood Pressure)
06/2005 - 11/2002
2Left Ventricular Dysfunction
06/2005 - 05/2005
1Hereditary Complement Deficiency Diseases
02/2018
1Chronic Obstructive Pulmonary Disease (COPD)
01/2016
1Rheumatoid Arthritis
09/2012
1Invasive Pulmonary Aspergillosis
06/2012
1Neoplasms (Cancer)
06/2010
1Boutonneuse Fever (Mediterranean Spotted Fever)
01/2009
1Acquired Immunodeficiency Syndrome (AIDS)
01/2009
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
09/2007
1Fibrosis (Cirrhosis)
12/2006

Drug/Important Bio-Agent (IBA)

12CytokinesIBA
09/2013 - 06/2003
12ChemokinesIBA
02/2009 - 07/2002
7LigandsIBA
10/2009 - 10/2003
6Immunoglobulins (Immunoglobulin)IBA
02/2018 - 04/2005
6Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2008 - 01/2003
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2010 - 11/2002
4Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
02/2018 - 04/2003
4Toll-Like Receptors (Toll-Like Receptor)IBA
05/2011 - 07/2004
4CD40 Ligand (CD40L)IBA
08/2006 - 01/2003
3InterleukinsIBA
06/2012 - 06/2003
3Interleukin-10 (Interleukin 10)IBA
01/2009 - 06/2003
3LipidsIBA
05/2008 - 02/2005
3Thalidomide (Thalomid)FDA Link
12/2006 - 11/2002
3Proteins (Proteins, Gene)FDA Link
10/2006 - 07/2002
3Toll-Like Receptor 2IBA
10/2006 - 07/2004
3RANK LigandIBA
05/2006 - 05/2005
3OsteoprotegerinIBA
05/2006 - 05/2005
2EnzymesIBA
02/2018 - 05/2009
2Chemokine CCL5IBA
06/2012 - 01/2006
2Interleukin-8 (Interleukin 8)IBA
06/2012 - 07/2002
2Chemokine CX3CL1IBA
02/2009 - 09/2007
2Apolipoproteins E (ApoE)IBA
01/2009 - 04/2006
2CXC ChemokinesIBA
05/2008 - 10/2006
2Pharmaceutical PreparationsIBA
12/2006 - 11/2005
2Matrix Metalloproteinases (MMPs)IBA
04/2006 - 05/2005
2Messenger RNA (mRNA)IBA
04/2006 - 07/2002
2Interleukin-7 (Interleukin 7)IBA
04/2005 - 06/2003
2activin AIBA
07/2004 - 03/2004
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2004 - 07/2002
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2004 - 07/2002
2Interferon-gamma (Interferon, gamma)IBA
10/2003 - 09/2003
2N 30IBA
06/2003 - 07/2002
1ImmunosorbentsIBA
02/2018
1Complement System Proteins (Complement)IBA
02/2018
1Vitamin DFDA LinkGeneric
01/2016
1Serum AlbuminIBA
01/2016
1Immunosuppressive Agents (Immunosuppressants)IBA
09/2012
1Immunomodulating AgentsIBA
09/2012
1Rituximab (Mabthera)FDA Link
09/2012
1Biomarkers (Surrogate Marker)IBA
06/2012
1Inflammation MediatorsIBA
06/2012
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2012
1Immunologic Factors (Immunomodulators)IBA
06/2010
1Immunoglobulin M (IgM)IBA
06/2010
1Immunoglobulin G (IgG)IBA
06/2010
1Immunoglobulin A (IgA)IBA
06/2010
1Thrombin Receptors (Thrombin Receptor)IBA
10/2009
1thrombin receptor peptide (42-47)IBA
10/2009
1Biological ProductsIBA
06/2009
1Urokinase Plasminogen Activator ReceptorsIBA
06/2009
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2009
1Plasminogen Activators (Plasminogen Activator)IBA
06/2009
1Lipocalin-2IBA
05/2009
1Interleukin-1beta (Interleukin 1 beta)IBA
05/2009
1Peptide Hydrolases (Proteases)FDA Link
01/2009
1Nicotinamide PhosphoribosyltransferaseIBA
02/2007
1CollagenIBA
12/2006
1connective tissue-activating peptide (CTAP-III)IBA
10/2006
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2006
1Intravenous Immunoglobulins (IVIG)FDA Link
09/2006
1PerforinIBA
04/2006

Therapy/Procedure

5Therapeutics
09/2012 - 01/2003
3Highly Active Antiretroviral Therapy (HAART)
01/2009 - 04/2003
2Heart Transplantation (Grafting, Heart)
05/2006 - 09/2003
1Immunomodulation
09/2012